RAPT Therapeutics, Inc. (RAPT) has a consensus analyst rating of Hold, based on 15 analysts covering the stock. Of those, 4 recommend buying, 11 recommend holding, and 0 recommend selling.
The analyst consensus price target for RAPT is $30.71, representing a -47.1% downside from the current price of $58.005. Price targets range from a low of $2.00 to a high of $55.00.
